Recombinant LH administration in subsequent cycle after “unexpected” poor response to recombinant FSH monotherapy.

References

• Oudendijk JF, Yarde F, Eijkemans MJ, et al. The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update 2012;18:1–11
   PubMed Web of Science ®Google Scholar
• Sunkara SK, Rittenberg V, Raine-Fenning N, et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 2011;26:1768–74
   PubMed Web of Science ®Google Scholar
• Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE Working Group on Poor Ovarian Response Definition ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–24
   PubMed Web of Science ®Google Scholar
• Hugues JN, Theron-Gerard L, Coussieu C, et al. Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal/stimulated steroid levels. Hum Reprod 2010;25:228–34
   PubMed Web of Science ®Google Scholar
• Sowers MF, Beebe JL, McConnell D, et al. Testosterone concentrations in women aged 25–50 years: associations with lifestyle, body composition, and ovarian status. Am J Epidemiol 2001;153:256–64
   PubMed Web of Science ®Google Scholar
• Piltonen T, Koivunen R, Ruokonen A, Tapanainen JS. Ovarian age-related responsiveness to human chrorionic gonadotrophin. J Clin Endocrinol Metab 2003;88:3327–32
   PubMed Web of Science ®Google Scholar
• Erickson GF, Wang C, Hsueh AJ. FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature 1979;279:336–8
   PubMedGoogle Scholar
• Shima K, Jitayama S, Nakano R. Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstet Gynaecol 1987;69:800–6
   PubMed Web of Science ®Google Scholar
• Hillier SG, Whitelaw PF, Smyth CD. Follicular oestrogen synthesis: the ‘two-cell, two-gonadotrophin’ model revisited. Mol. Cell. Endocrinol 1994;100:511–54
   Google Scholar
• Filicori M, Cognigni GE, Ciampaglia W. Effects of LH on oocyte yield and developmental competence. Hum Reprod 2003;18:1357–8
   PubMedGoogle Scholar
• Alviggi C, Clarizia R, Pettersson K, et al. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2009;18:9–14
   PubMed Web of Science ®Google Scholar
• Alviggi C, Pettersson K, Longobardi S, et al. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol [serial online] 2013;11:51
   PubMed Web of Science ®Google Scholar
• Hugues JN. Assessment of theca cell function: a prerequisite to androgen or luteinizing hormone supplementation in poor responders. Fertil Steril 2013;99:333–6
   PubMed Web of Science ®Google Scholar
• Piltonen T, Koivunen R, Ruokonen A, Tapanainen JS. Ovarian age-related responsiveness to human chorionic gonadotropin. J Clin Endocrinol Metab 2003;88:3327–32
   PubMed Web of Science ®Google Scholar
• Lehert P, Kolibianakis EM, Venetis CA, et al. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol 2014;12:17
   PubMed Web of Science ®Google Scholar
• Ruvolo G, Bosco L, Pane A, et al. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil Steril 2007;87:542–6
   PubMed Web of Science ®Google Scholar
• Lisi F, Rinaldi L, Fishel S, et al. Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reprod Biomed Online 2001;3:190–4
   PubMedGoogle Scholar
• Ferraretti AP, Gianaroli L, Magli MC, et al. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004;82:1521–6
   PubMed Web of Science ®Google Scholar
• Biasoni V, Patriarca A, Dalmasso P, et al. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reprod Biol Endocrinol 2011;9:112
   PubMed Web of Science ®Google Scholar
• Revelli A, Chiado' A, Guidetti D, et al. Outcome of in vitro fertilization in patients with proven poor ovarian responsiveness after early versus mid-follicular LH exposure: a prospective, randomized, controlled study. J Assist Reprod Genet. 2012;29:869–75
   PubMed Web of Science ®Google Scholar
• Bosch E, Labarta E, Crespo J, et al. Impact of luteinizing hormone administration on gonadotropin-antagonist cycles: an age-adjusted analysis. Fertil Steril 2011;95:1031–6
   PubMed Web of Science ®Google Scholar
• La Marca A, Papaleo E, Grisendi V, et al. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles. BJOG 2012;119:1171–9
   PubMed Web of Science ®Google Scholar
• Calzi F, Papaleo E, Rabellotti E, et al. Exposure of embryos to oxygen at low concentration in a cleavage stage transfer program: reproductive outcomes in a time-series analysis. Clin Lab 2012;58:997–1003
   PubMed Web of Science ®Google Scholar
• Corti L, Papaleo E, Pagliardini L, et al. Fresh blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggering: a strategy in the context of the Italian law. Eur J Obstet Gynecol Reprod Biol 2013;171:73–7
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology – a systematic review. Hum Reprod Update 2007;13:433–44
   PubMed Web of Science ®Google Scholar
• Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 2002;8:413–21
   PubMed Web of Science ®Google Scholar
• Nielsen ME, Rasmussen IA, Kristensen SG, et al. In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA Mol. Hum Reprod 2011;17:63–70
   Google Scholar
• Balasch J, F abregues F. LH in the follicular phase: neither too high nor too low. Reprod Biomed Online 2006;12:406–15
   PubMed Web of Science ®Google Scholar
• Nyboeandersen A, Humaidan P, Fried G, et al; Nordic LH study group. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Hum Reprod 2008;23:427–34
   PubMed Web of Science ®Google Scholar
• Mochtar MH, Van der V, Ziech M, van Wely M. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles, Cochrane Database Syst Rev 2007;CD005070
   Google Scholar
• Zeleznik AJ, Hillier SG. The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynecol 1984;27:927–40
   PubMed Web of Science ®Google Scholar